Hologic Inc (NASDAQ:HOLX)

76.47
Delayed Data
As of Dec 02
 -0.52 / -0.68%
Today’s Change
59.78
Today|||52-Week Range
80.49
-0.12%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$18.8B

Company Description

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a portfolio of solutions for breast cancer care for radiology, pathology, and surgery. The Diagnostics segment consists of products used to aid in the screening and diagnosis of human diseases. The GYN Surgical segment involves the NovaSure Endometrial Ablation System, the MyoSure Hysteroscopic Tissue Removal System, and the Fluent Fluid Management System. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Contact Information

Hologic, Inc.
250 Campus Drive
Marlborough Massachusetts 01752
P:(508) 263-2900
Investor Relations:

Employees

Shareholders

Mutual fund holders63.91%
Other institutional35.36%
Individual stakeholders3.82%

Top Executives

Stephen P. MacMillanChairman, President & Chief Executive Officer
Karleen Marie ObertonChief Financial Officer
Paul MalenchiniChief Information Officer
Monica Aguirre BerthelotChief of Staff, Vice President
Marci J. LernerVice President & Treasurer